Overview
Cardiovascular Drugs and Therapy is dedicated to the development of cardiovascular drug, device, and cell therapy from bench to bedside. The journals takes a fresh and energetic look at advances in this dynamic field.
-
Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focuses on developments that include: hyperlipidemia, diabetes and other cardiometabolic conditions, atherosclerosis, ischemic syndromes, heart failure, cardiomyopathies, valvular heart disease, and arrhythmias.
These include mechanisms of action and signaling pathways, their potential for new drug development, novel indications for older drugs, genetic approach to treatment, and new directions in device and cell therapy, interventional and structural heart disease, and cardiac and vascular surgery, as well as their guideline-based utilization in real-world patient populations.
- Authoritative source for researchers and investigators aiming for breakthrough research as well as cardiologists seeking to best serve their patients.
- Focuses on developments in treatment of various cardiovascular conditions.
- Listed in Web of Science and PubMed/Medline among other abstracting and indexing services.
- International readership: North America, Asia, Europe, Middle East and South America
- Efficient handling with 18 days between submission and first decision, and 17 days between acceptance and online publication.
- High usage and wide distribution with a global readership.
- Editor-in-Chief
-
- Yochai Birnbaum
- Impact factor
- 3.4 (2022)
- 5 year impact factor
- 3.8 (2022)
- Submission to first decision (median)
- 8 days
- Downloads
- 529,058 (2023)
Latest articles
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Journal information
- Electronic ISSN
- 1573-7241
- Print ISSN
- 0920-3206
- Abstracted and indexed in
-
- BFI List
- BIOSIS
- Baidu
- Biological Abstracts
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Current Contents/Life Sciences
- Dimensions
- EBSCO
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature